Defining the most appropriate and beneficial use of wearable cardioverter-defibrillators. Developing methods to identify and treat patients at high personal risk for SCD who are not identi- fied by current ICD eligibility criteria. Defining the role of CMR in enhancing risk strati- fication for SCD. Increasing research funding in this area, through ex- isting and new mechanisms is critically important. Some have proposed research funding strategies that would offer business incentives to the insurance industries, while providing support for unresolved research goals. Such approaches should be tested. ACC/AHA TASK FORCE MEMBERS GlennN.Levine,MD,FACC,FAHA,Chair;PatrickT.O Gara, MD, MACC, FAHA, Chair-Elect; Jonathan L. Halperin, MD, FACC, FAHA, Immediate Past Chair*; Sana M. Al-Khatib, MD, MHS, FACC, FAHA; Joshua A. Beckman, MD, MS, FAHA; Kim K. Birtcher, MS, PharmD, AACC; Biykem Boz- kurt, MD, PhD, FACC, FAHA*; Ralph G. Brindis, MD, MPH, MACC*; Joaquin E. Cigarroa, MD, FACC; Anita Deswal, MD, MPH, FACC, FAHA; Lesley H. Curtis, PhD, FAHA*; Lee A. Fleisher, MD, FACC, FAHA; Federico Gentile, MD, FACC; Samuel Gidding, MD, FAHA*; Zachary D. Goldberger, MD, MS, FACC, FAHA; Mark A. Hlatky, MD, FACC, FAHA; John Ikonomidis, MD, PhD, FAHA; Jos A. Joglar, MD, FACC, FAHA; Laura Mauri, MD, MSc, FAHA; Barbara Rie- gel, PhD, RN, FAHA; Susan J. Pressler, PhD, RN, FAHA*; Duminda N. Wijeysundera, MD, PhD PRESIDENTS AND STAFF American College of Cardiology Mary Norine Walsh, MD, FACC, President Shalom Jacobovitz, Chief Executive Officer William J. Oetgen, MD, MBA, FACC, Executive Vice President, Science, Education, Quality, and Publishing Amelia Scholtz, PhD, Publications Manager, Science, Education, Quality, and Publishing American College of Cardiology/ American Heart Association Katherine A. Sheehan, PhD, Director, Guideline Strategy and Operations *Former Task Force member; current member during the writing effort. 